Tiantan Bio proposes 2024 dividend, plans 2025 interim payout

Beijing Tiantan Biological Products Corp (SSE:600161) has announced its proposed profit distribution plan for 2024, alongside a prospective interim dividend plan for 2025, as resolved at the company's recent ninth board meeting. Shareholders are slated to receive a cash dividend of 0.10 RMB per share (pre-tax), totaling 197.74 million RMB, contingent upon shareholder approval at the upcoming annual general meeting. The payout represents 12.76% of the net profit attributable to shareholders for the year. The company plans to maintain the total dividend amount even if the total share capital changes before the record date.